| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,303 |
12,374 |
$359K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13,436 |
11,414 |
$329K |
| S9083 |
Global fee urgent care centers |
3,777 |
3,214 |
$291K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,425 |
6,094 |
$168K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,849 |
2,443 |
$67K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,024 |
1,729 |
$67K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,888 |
1,455 |
$60K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
649 |
475 |
$15K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
610 |
465 |
$14K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
229 |
195 |
$9K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
281 |
254 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
195 |
128 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
336 |
213 |
$4K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
659 |
539 |
$4K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
243 |
203 |
$3K |
| 87070 |
|
88 |
65 |
$2K |
| 90686 |
|
107 |
102 |
$858.03 |
| 90756 |
|
13 |
13 |
$143.83 |
| 90674 |
|
66 |
66 |
$29.22 |
| 81003 |
|
14 |
14 |
$19.04 |
| 87184 |
|
86 |
63 |
$7.65 |